Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined (Atherogenic) Dyslipidemia”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Post-approval studies (Phase 4)Study completedNCT03615534
What this trial is testing

Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

Who this might be right for
Atherogenic DyslipidemiaObesity Associated Disorder
Lewai Sharki Abdulaziz, MSc PhD 161
Post-approval studies (Phase 4)Study completedNCT01384058
What this trial is testing

Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2Hypercholesterolemia
University Hospital Freiburg 41
Large-scale testing (Phase 3)Study completedNCT00639158
What this trial is testing

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

Who this might be right for
DyslipidemiasCoronary Heart DiseaseCombined (Atherogenic) Dyslipidemia+1 more
Abbott 543